FOX vs ORGO · P/E 13, rev $16.30B vs rev $482.0M
Fox Corp Class B (FOX) versus Organogenesis Holdings Inc (ORGO) — a side-by-side from cached financials, not a winner call.
Fox Corp Class B (FOX) is a entertainment company listed on US.
Organogenesis Holdings Inc (ORGO) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported FOX revenue for 2025-06-30 was $16.30B. Net income was $2.29B. Revenue was up 16.6% from 2024-06-30 to 2025-06-30. FOX currently screens at market cap $24.49B and trailing P/E 13.0.
Latest reported ORGO revenue for 2024-12-31 was $482.0M. Net income was $861.0K. Revenue was up 11.3% from 2023-12-31 to 2024-12-31. ORGO currently screens at market cap $301.1M.
FOX currently screens at market cap $24.49B and trailing P/E 13.0. ORGO currently screens at market cap $301.1M.
Not investment advice. Open the FOX and ORGO stock pages for the full models.
Not investment advice.